Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C
This study has been completed.
Study NCT00298714. Last updated on November 21, 2007.
Information provided by Hospital Clinic of Barcelona
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Hepatitis C
Liver Fibrosis
Additional conditions recognized in this trial
Fibrosis
Hepatitis
Hepatitis C
Hepatitis C, Chronic
Hepatitis, Chronic
Liver Cirrhosis
More general conditions related to this trial
Digestive System Diseases
Flaviviridae Infections
Hepatitis, Viral, Human
Liver Diseases
Pathologic Processes
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Losartan
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Hospital Clinic of Barcelona
Back to top of Main Content